Dynamics of Fatigue and Recovery in MMA Training

June 19, 2025 updated by: Joanna Ostapiuk-Karolczuk, Poznan University of Physical Education

Temporal Dynamics of Biochemical and Psychological Markers of Fatigue and Recovery in Mixed Martial Arts Athletes Undergoing Strength and Conditioning Training

This observational study aims to understand how strength and conditioning training impacts biochemical and psychological markers of fatigue and recovery in mixed martial arts (MMA) athletes. The main questions it aims to answer are:

How does a high-intensity training program affect key biochemical markers, such as cortisol, inflammation, and muscle damage indicators? How does this training influence psychological factors, such as stress, mood, and recovery states? Researchers will compare measurements taken at four time points during the study to see if the training program leads to changes in these markers and whether it effectively balances stress and recovery.

Participants will:

Undergo a structured strength and conditioning program for three weeks. Provide blood samples for biochemical analysis at four different times. Complete psychological questionnaires assessing mood, stress, and recovery states.

The findings aim to help optimize training programs and improve athlete well-being while minimizing the risk of overtraining.

Study Overview

Status

Completed

Conditions

Detailed Description

This study investigates the physiological and psychological responses of mixed martial arts (MMA) athletes to a structured high-intensity strength and conditioning training program. The primary focus is on monitoring temporal changes in key biochemical markers (e.g., cortisol, catecholamines, inflammatory cytokines) and psychological factors (e.g., mood profiles, stress, recovery states) to understand the balance between training-induced fatigue and recovery.

The study is conducted over three weeks, during which athletes follow a standardized training regimen comprising strength, endurance, and technical drills. Training intensity and volume are carefully managed, with no changes introduced during the observation period to ensure consistent data collection. Baseline measurements are taken 48 hours after a rest period to eliminate the effects of prior workouts.

Key Features:

Biochemical Analysis:

Blood samples are collected at four time points (pre-study, and after each training week) under standardized conditions, including morning fasting to minimize variability due to circadian rhythms.

Markers such as cortisol, catecholamines, hs-CRP, myoglobin, and urea are analyzed using validated ELISA protocols and biochemical kits.

Psychological Assessment:

The RESTQ-76 SPORT (Recovery-Stress Questionnaire for Athletes) and POMS (Profile of Mood States) questionnaires are administered before each blood sample collection to evaluate athletes' stress-recovery balance and mood states.

Training Protocol:

Athletes train six days a week for approximately 15 hours total per week. Training includes a mix of circuit training, weightlifting, technique drills, and sparring, designed to mimic typical MMA preparation.

Study Goals:

This study aims to determine the effects of a high-intensity training regimen on the interaction between physiological stress markers and psychological states. It seeks to provide insights into early indicators of overtraining and inform personalized approaches to athlete training that optimize performance while reducing injury risk.

By integrating biochemical and psychological data, this research highlights the need for a holistic approach to training management in MMA athletes, with implications for broader sports science and athletic performance enhancement.

Study Type

Observational

Enrollment (Actual)

20

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consisted of male mixed martial arts (MMA) athletes affiliated with a sports club, actively engaged in regular training. All participants had a minimum of five years of training experience and at least two years of competitive fighting experience. They trained at least three times per week, maintained a balanced diet throughout the study, and did not use anabolic steroids, nutritional supplements, or medications that could influence the study results. The study was conducted during a training program that was an integral part of their preparation for competition. Athletes with injuries, clinical conditions, or those undergoing weight-cutting periods were excluded to ensure homogeneity and reliability of the results.

Description

Inclusion Criteria:

  • Minimum of 5 years of training experience in mixed martial arts (MMA).
  • Training at least three times per week.
  • At least two years of competitive fighting experience.
  • Not using anabolic steroids, nutritional supplements, or medications that could influence study results.
  • Maintaining a balanced diet throughout the study.
  • Non-smoker.

Exclusion Criteria:

  • Presence of any injury or clinical condition preventing participation in the study.
  • Use of anti-inflammatory drugs.
  • Undergoing a weight-cutting period during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
MMA athletes
Healthy, trained athletes
Athletes train six days a week for three weeks, totaling approximately 15 hours of training per week. Training includes circuit training, weightlifting, technique drills, and sparring, designed to mimic typical MMA preparation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in cortisol level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of stress level.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in epinephrine level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of sympathetic nervous system activity
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in norepinephrine level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of sympathetic nervous system activity, indicating stress response.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in hs CRP level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker inflammatory response.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in total protein level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of protein catabolism, and recovery processes.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in urea level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of balance between protein breakdown and recovery.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in uric acid level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of oxidative stress and, purine metabolism.
At rest (before training), after the first week of training, and after the second and third weeks of training
Mood Profile of Athletes Before Exercise Test Using POMS Questionnaire.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
The Profile of Mood States (POMS) questionnaire measures mood states and emotional well-being.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in testosterone level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker of the anabolic processes level.
At rest (before training), after the first week of training, and after the second and third weeks of training
Changes from baseline in creatine kinase level.
Time Frame: At rest (before training), after the first week of training, and after the second and third weeks of training
Marker muscle damage.
At rest (before training), after the first week of training, and after the second and third weeks of training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2014

Primary Completion (Actual)

September 20, 2014

Study Completion (Actual)

May 30, 2015

Study Registration Dates

First Submitted

November 22, 2024

First Submitted That Met QC Criteria

November 27, 2024

First Posted (Actual)

November 29, 2024

Study Record Updates

Last Update Posted (Estimated)

June 25, 2025

Last Update Submitted That Met QC Criteria

June 19, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MMA546/11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is not a plan to make individual participant data (IPD) available because protecting participant confidentiality is a priority, especially given the sensitive nature of personal health and performance data collected in this study. Additionally, there may be limitations in data-sharing infrastructure and resources needed to anonymize and securely manage IPD for external access. Ensuring compliance with privacy regulations and ethical standards also restricts the feasibility of making IPD broadly available to other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Three-Week Strength and Conditioning Program

Subscribe